• FirefoxInstall the new Firefox »
  •  Dow Down1.46% Nasdaq Down1.01%

    AVEO Pharmaceuticals, Inc. (AVEO)

    1.60 Up 0.18(12.32%) 1:51PM EST - Nasdaq Real Time Price
    Add to Portfolio
    HeadlinesGet Headlines for:
    [audio] [audio] AVEO Oncology Biomarker Analysis from Phase 2 Clinical Study of Tivozanib in Patients with Advanced Colorectal Cancer (recorded earlier today)

    No headlines available for AVEO prior to November 7, 2012.